The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization

Cristiano Spadaccio1,2, Antonio Nenna3, David Rose4

  • 1Cardiac Surgery, Massachusetts General Hospital & Harvard Medical School, Boston, USA. cristianospadaccio@gmail.com.

Insights

Surgical revascularization improves survival in coronary artery disease by promoting blood vessel growth (angiogenesis and arteriogenesis). This review explores how these mechanisms enhance blood flow and preserve heart tissue, offering therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Interventional Cardiology
  • Translational Medicine

Background:

  • Surgical myocardial revascularization offers long-term survival benefits for patients with multivessel coronary artery disease.
  • The precise biological mechanisms driving these clinical benefits remain incompletely understood.
  • Coronary collateralization, through angiogenesis and arteriogenesis, is a key endogenous mechanism for preserving myocardial viability during ischemia and predicts survival in coronary artery disease.

Purpose of the Study:

  • To review existing clinical and basic science evidence on arteriogenesis and angiogenesis in coronary artery disease (CAD).
  • To analyze the role of these vascularization processes in the context of coronary revascularization procedures.
  • To elucidate the clinical significance and potential therapeutic applications of angiogenesis and arteriogenesis in CAD management.

Main Methods:

  • Comprehensive literature review of experimental and clinical studies.
  • Analysis of data on angiogenesis and arteriogenesis in both chronic CAD and post-revascularization settings.
  • Synthesis of evidence linking vascularization mechanisms to clinical outcomes and therapeutic strategies.

Main Results:

  • Evidence suggests myocardial revascularization can induce an angiogenetic response.
  • Revascularization procedures themselves may act as triggers for endogenous angiogenesis.
  • Coronary collateralization is a recognized predictor of long-term survival in CAD patients.

Conclusions:

  • Angiogenesis and arteriogenesis are crucial endogenous mechanisms in CAD, contributing to myocardial protection.
  • Myocardial revascularization may stimulate these vascularization processes, enhancing clinical benefits.
  • Further research into these mechanisms could unlock novel therapeutic strategies for CAD.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52